欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL

2026-07-14
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

2026-07-13
Japan Awards Global-First Reimbursement To Ishin’s Allostem, Heihe’s Risovalisib

2026-07-13
LEO Reports Phase II Pediatric Data As Tralokinumab Advances Through Phase III

2026-07-13
Pink Sheet Podcast: Complete Response Letter And DTC Ad Regulations, Potential US FDA Reorg

2026-07-13
Global Phase III Trial For Serum Institute/Visterra’s Dengue Candidate Sharing Voyxact Platform

2026-07-13
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2026

2026-07-12
Novo Nordisk Launches Once-Weekly Insulin Awiqli In India To Treat Type 1, Type 2 Diabetes

2026-07-12
WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing

2026-07-12
Pink Sheet Podcast: Complete Response Letter And DTC Ad Regulations, Potential US FDA Reorg

2026-07-12
Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept)

2026-07-12
Roche Pulls Plug On Two Antisense Oligonucleotide Programs In Huntington’s

2026-07-11